[1]
|
Shaib, Y. and El-Serag, H.B. (2004) The Epidemiology of Cholangiocarcinoma. Seminars in Liver Disease, 24, 115- 125. https://doi.org/10.1055/s-2004-828889
|
[2]
|
Blechacz, B.R. and Gores, G.J. (2008) Cholangiocarcinoma. Clinical Liver Disease, 12, 131-150.
https://doi.org/10.1016/j.cld.2007.11.003
|
[3]
|
Tomita, H., Tanaka, K., Tanaka, T. and Hara, A. (2016) Aldehyde Dehydrogenase 1A1 in Stem Cells and Cancer. Oncotarget, 7, 11018-11032. https://doi.org/10.18632/oncotarget.6920
|
[4]
|
Bellomo, C., Caja, L. and Moustakas, A. (2016) Transforming Growth Factor β as Regulator of Cancer Stemness and Metastasis. British Journal of Cancer, 115, 761-769. https://doi.org/10.1038/bjc.2016.255
|
[5]
|
Shi, Y. and Massagué, J. (2003) Mechanisms of TGF-Beta Signaling from Cellmembrane to the Nucleus. Cell, 113, 685-700. https://doi.org/10.1016/S0092-8674(03)00432-X
|
[6]
|
Paik, S.Y., Park, Y.N., Kim, H. and Park, C. (2003) Expression of Transforming Growth Factor-Beta1 and Transforming Growth Factor-Beta Receptors in Hepatocellular Carcinoma and Dysplastic Nodules. Modern Pathology, 16, 86- 96. https://doi.org/10.1097/01.MP.0000047308.03300.9C
|
[7]
|
Bedossa, P., Peltier, E., Terris, B., Franco, D. and Poynard, T. (1995) Transforming Growth Factor-Beta 1 (TGF-Beta 1) and TGF-Beta 1 Receptors in Normal, Cirrhotic, and Neoplastic Human Livers. Hepatology, 21, 760-766.
|
[8]
|
Tirado-Rodriguez, B., Ortega, E., Segura-Medina, P. and Huerta-Yepez, S. (2014) TGF-β1: An Im-portant Mediator of Allergic Disease and a Molecule with Dual Activity in Cancer Development. Journal of Immunology Research, Artical ID: 318481. https://doi.org/10.1155/2014/318481
|
[9]
|
Takanami, I., Imamura, T., Hashizume, T., Kikuchi, K., Yamamoto, Y. and Kodaira, S. (1994) Transforming Growth Factor Beta 1 as a Prognostic Factor in Pulmonary Adenocarcinoma. Journal of Clinical Pathology, 47, 1098-1100.
https://doi.org/10.1136/jcp.47.12.1098
|
[10]
|
Hazelbag, S., Kenter, G.G., Gorter, A. and Fleuren, G.J. (2004) Prognostic Relevance of TGF-Beta1 and PAI-1 in Cervical Cancer. International Journal of Cancer, 112, 1020-1028. https://doi.org/10.1002/ijc.20512
|
[11]
|
Ikeguchi, M., Iwamoto, A., Taniguchi, K., Katano, K. and Hirooka, Y. (2005) The Gene Expression Level of Transforming Growth Factor-Beta (TGF-Beta) as a Biological Prognostic Marker of Hepatocellular Carcinoma. Journal of Experimental & Clinical Cancer Research, 24, 415-421.
|
[12]
|
Ginestier, C., Hur, M.H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., Jacquemier, J., Viens, P., Kleer, C.G., Liu, S., Schott, A., Hayes, D., Birnbaum, D., Wicha, M.S. and Dontu, G. (2007) ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical Outcome. Cell Stem Cell, 1, 555-567.
https://doi.org/10.1016/j.stem.2007.08.014
|
[13]
|
Minato, T., Yamamoto, Y., Seike, J., Yoshida, T., Yamai, H., Takechi, H., Yuasa, Y., Furukita, Y., Goto, M., Bando, Y. and Tangoku, A. (2013) Aldehyde Dehydrogenase Expression Is Associated with Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma. Annals of Surgical Oncology, 20, 209-217.
https://doi.org/10.1245/s10434-012-2535-8
|
[14]
|
Wu, A., Luo, W., Zhang, Q., Yang, Z., Zhang, G., Li, S. and Yao, K. (2013) Aldehyde Dehydrogenase, a Functional Marker for Identifying Cancer Stem Cells in Human Carcinoma. Cancer Letter, 330, 181-189.
https://doi.org/10.1016/j.canlet.2012.11.046
|